- Home
- CDT vs NUWE Comparison
CDT vs NUWE Comparison
Compare CDT & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDT
- NUWE
- Stock Information
- Founded
- CDT 2019
- NUWE 1999
- Country
- CDT United States
- NUWE United States
- Employees
- CDT N/A
- NUWE N/A
- Industry
- CDT Biotechnology: Pharmaceutical Preparations
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CDT Health Care
- NUWE Health Care
- Exchange
- CDT Nasdaq
- NUWE Nasdaq
- Market Cap
- CDT 5.2M
- NUWE 5.2M
- IPO Year
- CDT N/A
- NUWE N/A
- Fundamental
- Price
- CDT $0.69
- NUWE $0.96
- Analyst Decision
- CDT
- NUWE Strong Buy
- Analyst Count
- CDT 0
- NUWE 1
- Target Price
- CDT N/A
- NUWE $17.00
- AVG Volume (30 Days)
- CDT 1.4M
- NUWE 83.4K
- Earning Date
- CDT 05-13-2025
- NUWE 05-06-2025
- Dividend Yield
- CDT N/A
- NUWE N/A
- EPS Growth
- CDT N/A
- NUWE N/A
- EPS
- CDT N/A
- NUWE N/A
- Revenue
- CDT N/A
- NUWE $8,740,000.00
- Revenue This Year
- CDT N/A
- NUWE $22.96
- Revenue Next Year
- CDT N/A
- NUWE $29.97
- P/E Ratio
- CDT N/A
- NUWE N/A
- Revenue Growth
- CDT N/A
- NUWE N/A
- 52 Week Low
- CDT $0.65
- NUWE $0.90
- 52 Week High
- CDT $350.00
- NUWE $14.35
- Technical
- Relative Strength Index (RSI)
- CDT 31.97
- NUWE 33.36
- Support Level
- CDT $0.65
- NUWE $0.91
- Resistance Level
- CDT $1.05
- NUWE $1.03
- Average True Range (ATR)
- CDT 0.14
- NUWE 0.07
- MACD
- CDT 0.07
- NUWE -0.01
- Stochastic Oscillator
- CDT 7.30
- NUWE 14.19
About CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.